Biochemical screens

Rishton, G. M. Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov. Today 2002, 8, 85-96. 

The most X-ray intensive screening method was described by Card et al. [8] on the design of phosphodiesterase (PDE) inhibitors (Figure 1.7). The authors initially biochemically screened a 20,000 member library of small molecular weight (120-350 MW) core scaffold compounds against 5-PDE isoforms at 200 pM. Multiple isoforms of PDE were used in order to eliminate the number of false positives obtained from the screen. There were 316... 

Fig. 1.8 The increase in potency against PDE4D of a scaffold inhibitor, identified by biochemical screening at high compound concentrations then confirmed by X-ray crystallography, through two iterations of chemistry.

Schmidt The screen that might give it to you is actually a biochemical screen for phosphorylation targets on cell cycle regulators. 

Huth JR, Mendoza R, OlejniczakET, etal. (2005) ALARM NMR A rapid and robust experimental method to detect reactive false positives in biochemical screens. /. Am. Chem. Soc. 127 217-224. 

Multiple chemical sensitivity (MCS) is characterized by a variety of adverse effects upon multiple organs that result from exposure to levels of common foods, drugs, and chemicals that do not affect most people. Symptoms include headaches, fatigue, lack of concentration, memory loss, asthma, and other often subjective responses following exposure. MCS has remained controversial because standard medical evaluations, such as blood biochemical screens, have failed to identify consistent physical or laboratory test abnormalities that would account for the symptoms. 

Liver disease is a continuum, ranging from abnormalities of liver function tests found on routine biochemical screening, with no adverse clinical consequences, to severe end-stage liver failure. 

Animals often use toxins to immobilise their prey, often insects. Wasps, bees, spiders, mites, scorpions, snakes and other reptiles are all capable of producing potent toxins many of which are insect specific. There is much work in progress around the world examining the opportunities that exist to exploit these toxins to produce new insecticides. This is usually undertaken in two different ways. The first is to determine the mode of action of the natural toxin and to use this novel effect to find synthetic compounds with insecticidal activity in biochemical screens. The second is to attempt to synthesise compounds with the same structural features of the natural toxin and hence with the same mode of action but with better stability following application. The types of compounds that are known are discussed by Blagbrough and Moya13 but none has been commercialised to date. 

There are various methods to conduct a fragment screening campaign. The most commonly utilized methods include various NMR techniques, mass spectrometry, SPR, and biochemical screens. X-ray crystallization is a preferred method since it provides a binding conformation, but can only be used when the target protein is well behaved. Various calorimetry techniques have also been used for fragment screening, but these have been less commonly utilized. The merits of each method have been discussed in the literature (26) and will not be outlined here. 

As indicated at the outset of this broad-based review, although of the order of ten thousand plant defensive compounds have been isolated and structurally characterized, only of the order of a thousand have so far been shown to interact with specific proteins and most of these biochemical sites of interaction are signal transduction components. The elucidation of such targets now permits rapid biochemical screening of complex ecosystems for plant-derived ligands for such proteins. 

The decision on what type of screen to use in FBDD is affected by many different factors availability of protein for screening, compound selection, throughput, turnaround and rate of false positives and negatives. The resolution of these questions from target assessment directly impact the possibilities in this section. If there is not sufficient protein for a biophysical screen, a biochemical screen is the only choice. Protein that is not stable for... 

Biochemical techniques. Conceptually the most straightforward approach to identifying fragments is through a functional (biochemical) screen if the target activity is affected by the compound, it is a hit . However, since fragments usually have relatively low binding... 

Figure 3.3 Process for the assembly and use of Evotec s fragment library for high-concentration biochemical screening.

In the initial stages of searching for active compounds, the number of compounds to be screened is often greater than 100,000 and can exceed 500,000. Even 1 million compounds or more may be screened in a single assay.14 For this reason, biochemical screens must be inexpensive and quick. Ideally, the screen is automated and performed by a robot. Solutions of all necessary reagents and compounds to be tested are loaded into the instrument. The robot, called a liquid handler, dispenses reagents and solutions into microtiter plates. 

While biochemical assays can provide receptor binding or enzyme inhibition information, they cannot determine how a compound behaves in a more complex cellular environment. Assays involving whole cells are required for this information. Compounds that show activity in a biochemical screen but fail in a cellular assay likely suffer from interference from the cell... 

---